Clinical Cardiology Alert – June 1, 2007
June 1, 2007
View Issues
-
Fish Oil Plus Statins
EPA treatment added to statins reduces nonfatal CHD events in hypercholesterolaemic Japanese patients. -
Statins and HDL Cholesterol
Rosuvastatin and atorvastatin at their maximal doses, favorably change HDL subpopulation levels, but rosuvastatin is significantly more potent than atorvastatin for this purpose -
Rosuvastatin Plus Ezetimib
Rosuvastatin plus ezetimibe may improve the management of high-risk patients by increasing the number that reach goal LDL cholesterol levels. -
CAD in Women
Women harbor less atherosclerotic plaque within their coronary arteries, despite the greater prevalence of atherogenic risk factors. -
Obesity in Ethnic Minorities
Revisions of BMI cut-points to define obesity in ethnic minorities may be warranted. -
Anticoagulation in Atrial Fibrillation
Appropriate and seemingly inappropriate use of anticoagulation is occurring among patients with atrial fibrillation. -
Brugada Syndrome in Children
In children affected by Brugada syndrome there is no male predominance, a very strong linkage to febrile episodes and a high incidence of SCN5A mutations. -
Pharmacology Watch
Sweeping new changes have been made to the guidelines for prevention of endocarditis in patients undergoing dental procedures. -
Clinical Briefs in Primary Care Supplement